CDSCO Medical Device Software Guidance 2026: New Regulatory Requirements for Manufacturers

CDSCO Medical Device Software Guidance New Regulatory Requirements for Manufacturers

Medical technology is changing rapidly. Today, many healthcare products use software to detect diseases, monitor patients, analyse medical information, and support treatment decisions.

However, medical software must meet specific regulatory requirements before it can be manufactured, imported, or sold in India.

The CDSCO Medical Device Software Guidance 2026 provides manufacturers, importers, software developers, and medical technology companies with greater clarity on the regulatory requirements for medical device software under the Medical Devices Rules, 2017.

The Central Drugs Standard Control Organisation published its final Guidance Document on Medical Device Software in 2026 to help stakeholders understand regulatory expectations, including classification, safety and performance, technical documentation, quality management, and post-market obligations.

This guide explains the key requirements in simple language and helps manufacturers understand how to prepare for regulatory compliance.

What Is Medical Device Software?

Medical Device Software is software intended by its manufacturer to perform a medical purpose, such as diagnosing, monitoring, preventing, or treating a disease or medical condition.

It may work independently or together with a physical medical device.

Examples include:

  • Software that analyses medical images to help detect diseases.
  • Applications that monitor patients’ health conditions.
  • Software that supports clinical diagnosis.
  • Digital therapeutic software intended to manage specific medical conditions.
  • Software that analyses data from connected medical devices.
  • Software used to monitor or support treatment decisions.

The regulatory status depends on the software’s intended medical purpose, not simply on the fact that it is used in healthcare.

Software intended only for general wellness, fitness, or lifestyle tracking may fall outside the medical device definition when it does not have a medical intended purpose.

What Is CDSCO Medical Device Software Guidance In 2026?

The CDSCO Medical Device Software Guidance 2026 is a guidance document issued by CDSCO to explain how medical device software is regulated under the Medical Devices Rules, 2017.

The guidance is intended to help manufacturers and other stakeholders understand how to prepare regulatory applications and supporting documentation.

It provides clarification on areas such as:

  • Scope and definition of medical device software.
  • Risk-based classification.
  • Applicable safety and performance requirements.
  • Technical documentation.
  • Quality Management System.
  • Software lifecycle management.
  • Risk management and cybersecurity.
  • Post-market monitoring and reporting.

The guidance is intended to support a more consistent understanding of regulatory requirements and improve patient safety, product quality, and regulatory compliance.

Important: CDSCO describes the guidance as an awareness and regulatory guidance document. Manufacturers should read it together with the applicable statutory provisions of the Drugs and Cosmetics Act, 1940, the Medical Devices Rules, 2017, and relevant CDSCO notifications.

Key Regulatory Requirements Under CDSCO Medical Device Software Guidance In 2026

The following are important areas manufacturers should understand when preparing their medical device software for the Indian market.

 Determine Whether Your Software Is a Medical Device

The first step is to identify whether your software meets the definition of a medical device under the applicable Indian regulations.

Manufacturers should clearly define:

  • The intended purpose of the software.
  • The medical condition or clinical need it addresses.
  • The intended users, such as healthcare professionals or patients.
  • The intended healthcare environment.
  • Whether the software operates independently or with another device.

For example, an application that only tracks daily steps may not be a medical device. However, software designed to analyse patient data and support the diagnosis of a disease may fall under medical device regulations.

 Identify the Applicable Risk Classification

Medical devices in India are classified according to their associated risk.

The applicable classification of medical device software depends on factors such as its intended purpose, the importance of its output, and the potential harm if the software provides incorrect information.

Manufacturers should:

  1. Review the applicable CDSCO risk classification list.
  2. Identify the relevant software category.
  3. Determine the applicable risk class.
  4. Check the licensing and documentation requirements for that class.
  5. Seek clarification from CDSCO if the classification is uncertain.

The risk classification can affect the regulatory authority, licensing route, and supporting documentation required.

Prepare Complete Technical Documentation

Technical documentation helps demonstrate that the software is safe, performs as intended, and meets the applicable regulatory requirements.

Manufacturers should prepare documentation covering:

DocumentPurpose
Software descriptionExplains the software and its intended purpose
Software architectureDescribes the software structure and components
Design and development recordsShows how the software was developed
Verification and validation reportsDemonstrates that the software works as intended
Risk management fileIdentifies and controls potential risks
Clinical or performance evidenceSupports the intended medical purpose
Cybersecurity documentationExplains security controls and risk management
Software lifecycle recordsDocuments development, maintenance, and changes

The exact documentation depends on the software’s intended purpose, risk class, and applicable regulatory requirements.

Establish a Quality Management System

A Quality Management System helps manufacturers develop, maintain, and control medical device software consistently.

Under the CDSCO Medical Device Software Guidance 2026, manufacturers should pay attention to quality processes that support software safety, reliability, and traceability.

A suitable QMS should address:

  • Software development and maintenance.
  • Document and record control.
  • Risk management.
  • Software verification and validation.
  • Change management.
  • Defect and complaint handling.
  • Cybersecurity management.
  • Corrective and preventive actions.

Manufacturers should review applicable quality standards, including ISO 13485, IEC 62304, and ISO 14971, where relevant to their product and regulatory requirements.

Manage Software Risks and Cybersecurity

Medical device software may face risks such as incorrect results, software failures, unauthorised access, data loss, and cybersecurity vulnerabilities.

Manufacturers should identify these risks and establish appropriate controls.

Important areas include:

  • Identifying potential software hazards.
  • Assessing the severity and probability of harm.
  • Evaluating cybersecurity risks.
  • Controlling access to sensitive information.
  • Protecting software from unauthorised changes.
  • Testing security measures.
  • Documenting residual risks.
  • Monitoring and addressing vulnerabilities.

Cybersecurity should be considered throughout the software lifecycle rather than only after product development.

Validate Software Performance and Usability

Software should be tested to confirm that it performs its intended medical function safely and effectively.

Manufacturers should consider:

  • Software functionality.
  • Accuracy and reliability.
  • User interface design.
  • Usability testing.
  • Performance in intended healthcare settings.
  • Compatibility with connected devices.
  • Clinical or performance evidence, where applicable.

For products intended for use in India, manufacturers should also consider relevant clinical workflows, user training, language accessibility, and healthcare infrastructure conditions.

Maintain Post-Market Monitoring and Software Updates

Regulatory responsibilities do not end when a medical device software product receives approval.

Manufacturers should establish procedures for monitoring the product after it enters the market.

These procedures may include:

  • Monitoring customer complaints.
  • Collecting information about software failures.
  • Reporting applicable adverse events.
  • Managing software updates.
  • Evaluating new cybersecurity vulnerabilities.
  • Implementing corrective actions.
  • Maintaining software performance records.
  • Assessing whether changes require regulatory approval.

The manufacturer should ensure that software updates do not introduce unacceptable risks or affect the product’s intended performance.

CDSCO Medical Device Software Guidance In 2026: Regulatory Classification

Understanding the applicable risk class is an important part of preparing a regulatory application.

The classification determines the regulatory pathway and the type of license or approval that may be required.

Risk ClassGeneral Risk LevelRegulatory Consideration
Class ALow riskApplicable manufacturing or import requirements
Class BLow-moderate riskApplicable manufacturing or import license
Class CModerate-high riskCentral licensing requirements generally apply
Class DHigh riskCentral licensing requirements generally apply

The actual classification of medical device software must be determined using the applicable CDSCO classification rules and lists.

Do not assume that all medical device software belongs to the same risk class. The classification depends on the product’s intended purpose and applicable rules.

Documents Required for Medical Device Software Regulatory Compliance

Manufacturers and importers should prepare their documents according to the applicable regulatory pathway.

Common documents may include:

  • Application in the applicable prescribed form.
  • Device description and intended purpose.
  • Software architecture and design documentation.
  • Risk management documentation.
  • Software verification and validation reports.
  • Clinical or performance evaluation evidence, where applicable.
  • Quality Management System documents.
  • Manufacturing site details.
  • Labeling and instructions for use.
  • Cybersecurity and software maintenance documentation.
  • Applicable declarations and undertakings.

Additional documents may be required depending on the product category, risk class, and whether the application is for manufacturing or import.

CDSCO Medical Device Software Guidance In 2026: Application Process

Step 1: Define the Intended Purpose

Clearly identify what the software is designed to do and whether it has a medical purpose.

Step 2: Determine the Regulatory Status

Check whether the product meets the definition of medical device software under the applicable regulations.

Step 3: Identify the Risk Class

Review the CDSCO classification list and identify the relevant risk category.

Step 4: Prepare Technical Documentation

Collect the required software development, validation, risk management, and quality documents.

Step 5: Complete the Applicable Application

Identify the correct application form and regulatory authority based on the software’s risk class and whether the application concerns manufacturing or import.

Step 6: Submit the Application

Submit the application through the applicable CDSCO online system with the required supporting documents and fees.

Step 7: Respond to Regulatory Queries

Review and respond to any questions or requests for clarification from the licensing authority.

Step 8: Maintain Regulatory Compliance

After approval, maintain applicable QMS, post-market monitoring, software change control, and reporting procedures. The exact process and forms may vary based on the product category and the applicable regulatory pathway.

How the 2026 Guidance Affects Medical Device Manufacturers

The CDSCO Medical Device Software Guidance 2026 provides manufacturers with greater clarity on regulatory expectations.

Businesses developing or importing medical software should review their existing compliance procedures and identify any gaps.

AreaWhat Manufacturers Should Review
Product classificationConfirm the applicable risk class
Software developmentReview development and lifecycle records
Technical documentationCheck completeness and accuracy
Quality managementMaintain appropriate QMS procedures
CybersecurityIdentify and manage security risks
Performance validationConfirm evidence supports intended use
Software updatesMaintain change control and traceability
Post-market complianceEstablish complaint and safety monitoring

This review can help manufacturers prepare stronger regulatory submissions and reduce the risk of incomplete applications.

Common Compliance Mistakes to Avoid

Manufacturers should avoid the following mistakes:

  1. Treating all healthcare software as medical device software.
  2. Using an incorrect risk classification.
  3. Submitting incomplete technical documentation.
  4. Ignoring software lifecycle requirements.
  5. Failing to document software validation.
  6. Overlooking cybersecurity risks.
  7. Making software changes without proper assessment.
  8. Ignoring post-market monitoring obligations.

A clear regulatory strategy can help businesses identify these issues before submitting their applications.

How ELT Corporate Helps with Medical Device Software Registration

ELT Corporate provides regulatory compliance assistance to medical device manufacturers, importers, and technology companies seeking regulatory approval in India.

Our team helps businesses understand the CDSCO Medical Device Software Guidance 2026 and prepare their regulatory applications according to the applicable requirements.

Our Services Include:

  • Regulatory Classification: Assistance in identifying the applicable medical device software risk class.
  • Registration and Licensing: Guidance on the applicable CDSCO manufacturing or import licensing process.
  • Technical Documentation: Assistance with preparing and reviewing required technical documents.
  • Quality Management Support: Guidance on applicable QMS requirements and documentation.
  • Regulatory Consultation: Support in understanding CDSCO requirements and regulatory procedures.
  • Application Assistance: Help with preparing applications and responding to regulatory queries.
  • Compliance Support: Guidance on applicable post-market and software change requirements.

Whether you are a startup developing medical software or an established manufacturer planning to enter the Indian market, ELT Corporate can help you understand the regulatory pathway and prepare your documentation.

Contact ELT Corporate for professional assistance with medical device software regulatory compliance in India.

Conclusion

The CDSCO Medical Device Software Guidance 2026 is an important regulatory reference for manufacturers, importers, and software developers planning to introduce medical device software in India.

Understanding the applicable classification, licensing requirements, technical documentation, quality management, cybersecurity, and post-market obligations can help businesses prepare for regulatory compliance.

Manufacturers should review their existing software development and regulatory processes to identify gaps and ensure that their products meet the applicable requirements under the Medical Devices Rules, 2017.

A well-planned regulatory strategy can help businesses reduce documentation errors, avoid unnecessary delays, and support the safe introduction of medical technology into the Indian market.

Frequently Asked Questions 

Q1. What is CDSCO Medical Device Software Guidance 2026?

It is a CDSCO guidance document explaining regulatory expectations for medical device software under the Medical Devices Rules, 2017, including classification, technical documentation, quality management, and safety requirements.

Q2. Is medical device software regulated in India?

Yes. Software intended for a medical purpose may be regulated as a medical device under the applicable Indian regulations.

Q3. What software is considered a medical device?

Software intended for medical purposes such as diagnosis, prevention, monitoring, treatment, or management of a disease or medical condition may qualify as medical device software.

Q4. Is CDSCO registration mandatory for medical device software?

The applicable regulatory approval or license depends on the product’s classification, intended purpose, and whether it is manufactured or imported in India.

Q5. How is medical device software classified in India?

Medical device software is classified according to its intended purpose and applicable risk-based classification rules under the Medical Devices Rules, 2017.

Q6. What documents are required for medical device software registration?

Common documents include the device description, intended purpose, technical documentation, risk management records, software validation reports, QMS documents, and applicable application forms.

Q7. Which standards are relevant to medical device software?

Relevant standards may include ISO 13485 for quality management, IEC 62304 for software lifecycle processes, and ISO 14971 for risk management, depending on the product and applicable requirements.

Comments are closed